Pelvic Inflammatory Disease
A spectrum of inflammation involving the female upper genital tract and the supporting tissues. It is usually caused by an ascending infection of organisms from the endocervix. Infection may be confined to the uterus (ENDOMETRITIS), the FALLOPIAN TUBES; (SALPINGITIS); the ovaries (OOPHORITIS), the supporting ligaments (PARAMETRITIS), or may involve several of the above uterine appendages. Such inflammation can lead to functional impairment and infertility.
Subtype terms (4)
More specific conditions that are subtypes of Pelvic Inflammatory Disease in the MeSH hierarchy.
- Endometritis
21 drugs approved
- Oophoritis
2 drugs approved
- Parametritis
2 drugs approved
- Salpingitis
2 drugs approved
Drugs by status
Approved for this indication (7)
Phase 4 trials (5)
Phase 3 trials (1)
Phase 2 trials (3)
Phase 1 trials (1)
Other trials (3)
Organizations
Organization Involved with Phase 4 Indications (12)
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Bakirkoy Dr. Sadi Konuk Research and Training Hospital
- China Academy of Chinese Medical Sciences
- Capital Medical University
- Peking University
- Tianjin University of Traditional Chinese Medicine
- Shanghai University
- Chengdu University of Traditional Chinese Medicines
- Guilin University
- Shenzhen maternal and child health care hospital
- Chinese Academy of Medical Sciences
- Heilongjiang University of Traditional Chinese Medicine
Organization Involved with Phase 3 Indications (1)
Organization Involved with Phase 2 Indications (5)
Organization Involved with Other Experimental Indications (3)